Variant report

Variant	nsv877763
Chromosome Location	chr3:162455815-162521339
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:10)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:10 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr3:162486396..162487274-chr3:162497260..162497768,2	MCF-7	breast:
2	chr3:162118223..162119105-chr3:162517137..162517997,2	MCF-7	breast:
3	chr3:162468849..162471720-chr3:162897232..162899564,2	K562	blood:
4	chr3:162449508..162452375-chr3:162459605..162462257,2	MCF-7	breast:
5	chr3:162475543..162478495-chr3:162480272..162482533,2	MCF-7	breast:
6	chr3:162471864..162474454-chr3:162482441..162485010,2	MCF-7	breast:
7	chr3:162471864..162474454-chr3:162482441..162485010,2	MCF-7	breast:
8	chr3:162475543..162478495-chr3:162480272..162482533,2	MCF-7	breast:
9	chr3:162494680..162495563-chr3:162760633..162761552,3	MCF-7	breast:
10	chr3:162486396..162487274-chr3:162497260..162497768,2	MCF-7	breast:

No data

Extended variants
information (count: 2383 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:2383 , 50 per page) page: 1 2 3 4 5 6 7 ... 48

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11928465	chr3:162455815-162455816	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs34673337	chr3:162455821-162455822	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs537926822	chr3:162455864-162455865	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs557137813	chr3:162455921-162455922	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs576658863	chr3:162455987-162455988	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs545569965	chr3:162456000-162456001	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs573212247	chr3:162456103-162456104	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs186812131	chr3:162456177-162456178	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs572789766	chr3:162456260-162456261	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs78060022	chr3:162456279-162456280	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs561477263	chr3:162456284-162456285	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs139506192	chr3:162456306-162456307	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs550369557	chr3:162456333-162456334	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs564187287	chr3:162456338-162456339	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs550397074	chr3:162456340-162456341	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs547207745	chr3:162456344-162456345	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs374397299	chr3:162456354-162456355	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs567181930	chr3:162456382-162456383	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs144237372	chr3:162456387-162456388	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs75745797	chr3:162456441-162456442	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs77259174	chr3:162456443-162456444	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs368356665	chr3:162456464-162456465	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs562638868	chr3:162456523-162456524	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs79062733	chr3:162456559-162456560	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs114875667	chr3:162456592-162456593	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs114066957	chr3:162456639-162456640	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs375481481	chr3:162456724-162456725	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs577710820	chr3:162456779-162456780	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs146562696	chr3:162456808-162456809	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs561155575	chr3:162456838-162456839	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs368463052	chr3:162456843-162456844	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs140085344	chr3:162456928-162456929	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs572803685	chr3:162457046-162457047	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs541729973	chr3:162457075-162457076	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs561738890	chr3:162457121-162457122	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs575160400	chr3:162457152-162457153	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs544193330	chr3:162457167-162457168	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs564068622	chr3:162457295-162457296	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs533019573	chr3:162457396-162457397	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs528713157	chr3:162457400-162457401	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs560643873	chr3:162457449-162457450	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs529631634	chr3:162457457-162457458	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs140081727	chr3:162457487-162457488	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs190557034	chr3:162457503-162457504	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs143762376	chr3:162457507-162457508	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs551740085	chr3:162457521-162457522	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs183138822	chr3:162457589-162457590	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs533982566	chr3:162457655-162457656	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs546910788	chr3:162457700-162457701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs552769328	chr3:162457702-162457703	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	16608533	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-small cell lung cancer	19010865	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16547154	CNVD
Breast cancer	21364760	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Prostate cancer	16573809	CNVD
Breast cancer	21785460	CNVD
Sudden cardiac death	19188705	CNVD
Mantle cell lymphoma	19029149	CNVD
Malformation	19546859	CNVD
Schizophrenia	19546859	CNVD
Breast cancer	17133270	CNVD
Myelofibrosis	22110671	CNVD
Hirschsprung''s Disease	21712996	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
epilepsy	18472482	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Myxofibrosarcoma	16751306	CNVD
Parkinson disease	21907011	CNVD
Bladder cancer	21909424	CNVD
Chordoma	21215367	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:136 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:162439800-162459200	Weak transcription	H1 Cell Line	embryonic stem cell
2	chr3:162453800-162457000	Enhancers	HUES64 Cell Line	embryonic stem cell
3	chr3:162454200-162458000	Weak transcription	HUES6 Cell Line	embryonic stem cell
4	chr3:162454400-162456000	Weak transcription	Dnd41	blood
5	chr3:162454400-162456200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
6	chr3:162454400-162456600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
7	chr3:162454400-162458000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
8	chr3:162454600-162458000	Weak transcription	HUES48 Cell Line	embryonic stem cell
9	chr3:162455000-162458200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
10	chr3:162456000-162457000	Enhancers	Dnd41	blood
11	chr3:162456200-162456400	Enhancers	ES-I3 Cell Line	embryonic stem cell
12	chr3:162456400-162457800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr3:162456600-162461400	Enhancers	iPS-15b Cell Line	embryonic stem cell
14	chr3:162457000-162458200	Weak transcription	HUES64 Cell Line	embryonic stem cell
15	chr3:162457800-162458200	Enhancers	ES-I3 Cell Line	embryonic stem cell
16	chr3:162458000-162458400	Enhancers	iPS-20b Cell Line	embryonic stem cell
17	chr3:162458000-162460200	Enhancers	HUES48 Cell Line	embryonic stem cell
18	chr3:162458000-162460200	Enhancers	HUES6 Cell Line	embryonic stem cell
19	chr3:162458200-162459400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
20	chr3:162458200-162459800	Enhancers	HUES64 Cell Line	embryonic stem cell
21	chr3:162458200-162460400	Enhancers	iPS-18 Cell Line	embryonic stem cell
22	chr3:162458400-162459000	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
23	chr3:162459000-162459400	Active TSS	iPS-20b Cell Line	embryonic stem cell
24	chr3:162459200-162459800	Enhancers	H1 Cell Line	embryonic stem cell
25	chr3:162459400-162459800	Genic enhancers	ES-I3 Cell Line	embryonic stem cell
26	chr3:162459400-162459800	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
27	chr3:162459800-162460200	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr3:162459800-162461200	Enhancers	iPS-20b Cell Line	embryonic stem cell
29	chr3:162459800-162461600	Weak transcription	HUES64 Cell Line	embryonic stem cell
30	chr3:162460200-162460600	Weak transcription	HUES48 Cell Line	embryonic stem cell
31	chr3:162460200-162461400	Genic enhancers	ES-I3 Cell Line	embryonic stem cell
32	chr3:162460200-162463600	Weak transcription	HUES6 Cell Line	embryonic stem cell
33	chr3:162460400-162461000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
34	chr3:162460600-162461200	Enhancers	HUES48 Cell Line	embryonic stem cell
35	chr3:162460600-162461200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
36	chr3:162460800-162461200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
37	chr3:162461000-162461200	Enhancers	iPS-18 Cell Line	embryonic stem cell
38	chr3:162461200-162462200	Weak transcription	HUES48 Cell Line	embryonic stem cell
39	chr3:162461200-162462800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
40	chr3:162461400-162462600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
41	chr3:162461600-162462400	Enhancers	HUES64 Cell Line	embryonic stem cell
42	chr3:162462200-162462400	Enhancers	HUES48 Cell Line	embryonic stem cell
43	chr3:162462600-162463200	Strong transcription	ES-I3 Cell Line	embryonic stem cell
44	chr3:162462800-162463000	Enhancers	iPS-20b Cell Line	embryonic stem cell
45	chr3:162463200-162464200	ZNF genes & repeats	ES-I3 Cell Line	embryonic stem cell
46	chr3:162463600-162465800	ZNF genes & repeats	HUES6 Cell Line	embryonic stem cell
47	chr3:162464800-162465800	ZNF genes & repeats	HUES64 Cell Line	embryonic stem cell
48	chr3:162465800-162469800	Weak transcription	HUES6 Cell Line	embryonic stem cell
49	chr3:162466800-162468200	Enhancers	ES-I3 Cell Line	embryonic stem cell
50	chr3:162468200-162470200	Weak transcription	ES-I3 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links